F J Prins - JoVE Visualize

Showing results (1-10 of 6) with videos related to

Pageof 1

Sort By:

European Journal of Clinical Pharmacology|January 1, 1992

Temporary reversal of serum to cerebrospinal fluid glycerol concentration gradient after intravenous infusion of glycerolR Nau, F J Prins, H Kolenda, et al.

British Journal of Haematology|March 23, 1999

Thromboxane-dependent platelet activation in vivo precedes arterial thrombosis in thrombocythaemia: a rationale for the use of low-dose aspirin as an antithrombotic agentP J van Genderen, F J Prins, J J Michiels, et al.

Thrombosis and Haemostasis|September 1, 1996

Erythromelalgia in essential thrombocythemia is characterized by platelet activation and endothelial cell damage but not by thrombin generationP J van Genderen, I S Lucas, R van Strik, et al.

British Journal of Haematology|January 31, 1998

Decreased half-life time of plasma von Willebrand factor collagen binding activity in essential thrombocythaemia: normalization after cytoreduction of the increased platelet countP J van Genderen, F J Prins, I S Lucas, et al.

Annals of Hematology|January 20, 1998

Excessive prolongation of the bleeding time by aspirin in essential thrombocythemia is related to a decrease of large von Willebrand factor multimers in plasmaP J van Genderen, H H van Vliet, F J Prins, et al.

Thrombosis Research|November 15, 2025

Predicting clinically relevant bleeding in new-onset atrial fibrillation patients initiating oral anticoagulant therapy: External validation of the AF-BLEED scoreS F B van der Horst, G Chu, J Seelig, et al.

Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:

Pageof 1

European Journal of Clinical Pharmacology|January 1, 1992

Temporary reversal of serum to cerebrospinal fluid glycerol concentration gradient after intravenous infusion of glycerolR Nau, F J Prins, H Kolenda, et al.

British Journal of Haematology|March 23, 1999

Thromboxane-dependent platelet activation in vivo precedes arterial thrombosis in thrombocythaemia: a rationale for the use of low-dose aspirin as an antithrombotic agentP J van Genderen, F J Prins, J J Michiels, et al.

Thrombosis and Haemostasis|September 1, 1996

Erythromelalgia in essential thrombocythemia is characterized by platelet activation and endothelial cell damage but not by thrombin generationP J van Genderen, I S Lucas, R van Strik, et al.

British Journal of Haematology|January 31, 1998

Decreased half-life time of plasma von Willebrand factor collagen binding activity in essential thrombocythaemia: normalization after cytoreduction of the increased platelet countP J van Genderen, F J Prins, I S Lucas, et al.

Annals of Hematology|January 20, 1998

Excessive prolongation of the bleeding time by aspirin in essential thrombocythemia is related to a decrease of large von Willebrand factor multimers in plasmaP J van Genderen, H H van Vliet, F J Prins, et al.

Thrombosis Research|November 15, 2025

Predicting clinically relevant bleeding in new-onset atrial fibrillation patients initiating oral anticoagulant therapy: External validation of the AF-BLEED scoreS F B van der Horst, G Chu, J Seelig, et al.

Pageof 1